PARIS, Dec. 19, 2024 /PRNewswire/ -- Astraveus SAS ("Astraveus" or the "Company"), the Benchtop Cell Factory company aiming for maximized cell quality and order-of-magnitude cost reduction in cell therapy manufacturing, today announces that the Company has been awarded a non-dilutive...
Read More Details
Finally We wish PressBee provided you with enough information of ( Astraveus Secures €7.1M Non-dilutive Funding from the French State )
Also on site :